Rutilio Fratti

Rutilio Fratti serves as a Professor in the Department of Biochemistry at the University of Illinois at Urbana-Champaign, investigating protein-lipid interactions and membrane fusion mechanisms with implications for cancer, diabetes, and Alzheimer's disease.

His academic credentials include:

• B.S. from California State University, Long Beach (1992)
• Ph.D. from the University of Michigan (2002)
• Postdoctoral fellowship at Dartmouth Medical School (2002-2006)

Fratti's research examines how regulatory lipids (phosphatidic acid, diacylglycerol, phosphoinositides, cholesterol, sphingolipids) in membrane microdomains control SNARE-mediated fusion events in Saccharomyces cerevisiae vacuoles. His lab demonstrates that lipid composition dynamically regulates membrane properties like curvature and fluidity, with dysregulation directly linked to disease pathogenesis. This work bridges fundamental biophysics with therapeutic applications through lipid-targeted interventions.

Analysis of his 2024-2025 publications reveals three dominant research vectors: (1) advanced biophysical techniques (spectroscopy, bio-layer interferometry) for quantifying protein-lipid binding dynamics, (2) mechanistic studies of antifungal compounds against pathogens like Rhizopus and Candida, and (3) elucidation of sphingolipid roles in vacuolar tethering/fusion stages through genetic and biochemical approaches.

No scientific awards were documented in the provided materials.

The source text contains no references to graduate students, postdoctoral researchers, or research funding sources under Professor Fratti's supervision.

He directs the Fratti Lab, which employs yeast vacuoles and synthetic vesicle systems to dissect lipid-driven regulation of membrane fusion. Current projects focus on lipid modification enzymes, microdomain assembly, and pathogen-host membrane interaction mechanisms using combinatorial biochemical and genetic approaches.